kyoto.jpeg

kyoto

kyotovisitorshost.jpeg

kyotovisitorshost

General information

Announcements(0)

Overview

Pre-registration

Abstract Submission (Oral/Poster Presentation)

Guidelines for Writing Abstracts (Oral/Poster Pres

Program

Sessions

Search presentations

pharm140_e.png

icon_20251203154432448.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts.<br>If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.<br>We will reply after confirming that you were a participant.<br>Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Timetable

Pharmacokinetics/pharmacodynamic modeling to link pharmacokinetics to efficacy and drug interaction of Alzheimer's disease drugs

In an aging society with an extended life expectancy, dementia has become a major public health problem, and the number of patients with dementia continues to increase. There are high unmet medical needs (medical needs that have not been satisfied yet) for dementia, and a drug discovery for fundamental treatment is essential to move beyond current symptomatic treatment. In addition, as a countermeasure against dementia, the Japanese government strongly promotes strategies that prevent, delay the onset of, and suppress the progression of dementia. However, development of new mechanisms underlying dementia treatment and prevention have not been successful so far, and drug discovery targets from a new perspective are required.<br> In this symposium, six speakers from pharmacology, physical chemistry, bioanalytical chemistry, pharmacokinetics, and pharmacotherapeutics will discuss the development of new therapeutic drugs and the establishment of diagnosis and prevention methods across various fields. In addition, perspectives of future dementia research, drug discovery applications, and drug development will be discussed. Through this symposium, our goals are to share multidisciplinary approaches to dementia research, expand our research capabilities, and discover new mechanisms of action that can lead to the development of innovative new therapeutic and preventive treatments for dementia.

A multi-faceted approach to dementia treatment by young researchers

The 140th Annual Meeting of the Pharmaceutical Society of Japan (Kyoto)

Presentation Information

[S17-3]Pharmacokinetics/pharmacodynamic modeling to link pharmacokinetics to efficacy and drug interaction of Alzheimer's disease drugs

Password required to view